Keywords: astrazeneca, crestor, off, strong, start, usa, overall
AstraZeneca's Crestor off to strong start in USA; overall performance on track
Article | 13 October 2003
Anglo-Swedish drug major AstraZeneca says that its much-trumpeted new cholesterol-lowerer Crestor (rosuvastatin) has got off to a good start in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
